NYSEARCA:BBH

Vaneck Vectors Biotech Etf ETF News

etoro logo Buy BBH
*Your capital is at risk
$205.55
-2.46 (-1.18%)
At Close: Jul 31, 2026
Gilead Sciences (GILD) has ignited a ray of hope with its recently-released positive data on the role of remdesivir as a COVID-19 treatment.
Gilead Sciences (GILD) has ignited a ray of hope with its recently-released positive data on the role of remdesivir as a COVID-19 treatment.
Bank of America Corp DE lessened its holdings in shares of VanEck Vectors Biotech ETF (NASDAQ:BBH) by 7.1% in the 4th quarter, HoldingsChannel reports. The firm owned 32,047 shares of the company’s
Stocks Analysis by Zacks Investment Research covering: Roche Holding AG Participation, Sanofi SA, Gilead Sciences Inc, Amgen Inc. Read Zacks Investment Research's latest article on Investing.com
Yes, many biotech stocks are down at the moment. But that sets up an incredible chance to get some of the best at a discount.

Best Biotech ETFs for Q2 2020

09:03pm, Tuesday, 07'th Apr 2020
Biotech companies use or modify biological processes usually in order to create new pharmaceuticals or therapies. The biotech sector, is particularly hot right now as biotech companies around the worl
The World Health Day of 2020 puts these medical companies and the related stocks and ETFs in focus.
The World Health Day of 2020 puts these medical companies and the related stocks and ETFs in focus.
Advisor Group Inc. reduced its position in VanEck Vectors Biotech ETF (NASDAQ:BBH) by 32.9% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor
After one of the worst Q1, get ready for a coronavirus-riddled Q2 which makes these industries and ETFs worth a bet. These areas emerged as the top performers of Q1.
Growing coronavirus concerns provide some support to these biotech ETFs and stocks amid a massive market sell-off.
VanEck Vectors Biotech ETF (NASDAQ:BBH) was downgraded by ValuEngine from a “hold” rating to a “sell” rating in a report released on Tuesday, ValuEngine reports. NASDAQ:BBH opened at $114.60 o
Stocks Analysis by Zacks Investment Research covering: S&P 500, Dow Jones Industrial Average, Gilead Sciences Inc, Biogen Inc. Read Zacks Investment Research's latest article on Investing.com
Fmr LLC reduced its stake in shares of VanEck Vectors Biotech ETF (NASDAQ:BBH) by 31.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchan
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE